VLKIM
ELV icon

Van Lanschot Kempen Investment Management’s Elevance Health ELV Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
303
-111
-27% -$41.2K ﹤0.01% 234
2026
Q1 		$121K Sell
414
-280
-40% -$92K ﹤0.01% 234
2025
Q4 		$243K Sell
694
-4,346
-86% -$1.47M ﹤0.01% 235
2025
Q3 		$1.63M Sell
5,040
-10,517
-68% -$3.27M 0.01% 224
2025
Q2 		$6.05M Buy
15,557
+4,565
+42% +$1.84M 0.06% 201
2025
Q1 		$4.78M Buy
10,992
+402
+4% +$161K 0.05% 188
2024
Q4 		$3.91M Sell
10,590
-88
-0.8% -$36.8K 0.04% 192
2024
Q3 		$5.55M Sell
10,678
-70
-0.7% -$37.4K 0.06% 162
2024
Q2 		$5.82M Buy
10,748
+2,863
+36% +$1.51M 0.07% 154
2024
Q1 		$4.09M Buy
7,885
+926
+13% +$461K 0.05% 166
2023
Q4 		$3.28M Buy
6,959
+1,300
+23% +$601K 0.05% 164
2023
Q3 		$2.46M Sell
5,659
-384
-6% -$174K 0.05% 156
2023
Q2 		$2.68M Sell
6,043
-1,613
-21% -$744K 0.05% 157
2023
Q1 		$3.52M Buy
7,656
+415
+6% +$197K 0.07% 142
2022
Q4 		$3.71M Buy
7,241
+710
+11% +$360K 0.11% 125
2022
Q3 		$2.97M Buy
6,531
+384
+6% +$184K 0.12% 122
2022
Q2 		$2.97M Buy
6,147
+238
+4% +$118K 0.11% 124
2022
Q1 		$2.9M Buy
+5,909
New +$2.7M 0.09% 126
2020
Q2 		– Sell
-297
Closed -$67K – 173
2020
Q1 		$67K Hold
297
– – 0.01% 169
2019
Q4 		$90K Sell
297
-5,286
-95% -$1.45M 0.01% 178
2019
Q3 		$1.34M Sell
5,583
-628
-10% -$172K 0.11% 115
2019
Q2 		$1.75M Sell
6,211
-2,815
-31% -$769K 0.15% 113
2019
Q1 		$2.59M Buy
+9,026
New +$2.61M 0.24% 96

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Van Lanschot Kempen Investment Management's ELV Position: Q2 2026 in Review

Van Lanschot Kempen Investment Management reduced its Elevance Health (ELV) stake by 27% in Q2 2026, selling an estimated $41.2K and leaving 303 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #234.

Van Lanschot Kempen Investment Management first reported a position in ELV in Q1 2019 and has held it in 23 quarters since. The position peaked at $6.05M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Van Lanschot Kempen Investment Management held 303 shares of Elevance Health worth $117K as of Q2 2026.
  • Van Lanschot Kempen Investment Management sold 111 Elevance Health shares in Q2 2026, an estimated $41.2K.
  • Elevance Health made up ﹤0.01% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #234 holding.
  • Van Lanschot Kempen Investment Management first reported a position in Elevance Health in Q1 2019 and has held it in 23 quarters since.
  • Van Lanschot Kempen Investment Management's Elevance Health position peaked at $6.05M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.